Enhanced Angiotensin II type 1 receptor expression in leukocytes of patients with chronic kidney disease

European Journal of Pharmacology

Volumn 666, Issue 1-3, 2011, Pages 205-210

  Chon, Helena ^a,b   Neumann, Jutta ^a   Boer, Peter ^a   Joles, Jaap A ^a   Braam, Branko ^c,d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Tergooiziekenhuizen   (Netherlands)

^c UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^d Dept Physiology ^*  (Canada)

Author keywords

Angiotensin AT1 receptor antagonist; Angiotensin converting enzyme inhibitor; Cholesterol; Chronic kidney disease; Circulating cells; Hypertension; Inflammation; Leukocyte; Lipids; Oxidative stress; Renin angiotensin system; Statin

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ARYLDIALKYLPHOSPHATASE; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN A; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; KIDNEY FUNCTION; LEUKOCYTE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BLOOD PRESSURE; CHRONIC DISEASE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY DISEASES; LEUKOCYTES; MALE; MIDDLE AGED; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM;

EID: 79959991657     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.05.028     Document Type: Article

References (34)

1. S. Abdalla, H. Lother, A. Langer, Y. El Faramawy, and U. Quitterer Factor XIIIA transglutaminase crosslinks AT(1) receptor dimers of monocytes at the onset of atherosclerosis Cell 119 2004 343 354 (Pubitemid 39423837)
2. A. Bellucci, and B.M. Wilkes Mechanism of sodium modulation of glomerular angiotensin receptors in the rat J. Clin. Invest. 74 1984 1593 1600 (Pubitemid 15214070)
3. Y.V. Bobryshev Dendritic cells and their involvement in atherosclerosis Curr. Opin. Lipidol. 11 2000 511 517
4. C. Borghi, S. Bacchelli, D.D. Esposti, and E. Ambrosioni Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction Diabetes Care 26 2003 1862 1868 (Pubitemid 36929134)
5. B. Braam, and H.A. Koomans Renal responses to antagonism of the renin-angiotensin system Curr. Opin. Nephrol. Hypertens. 5 1996 89 96 (Pubitemid 26088564)
6. A.R. Brasier, A. Recinos III, and M.S. Eledrisi Vascular inflammation and the renin-angiotensin system Arterioscler. Thromb. Vasc. Biol. 22 2002 1257 1266 (Pubitemid 34875734)
7. H. Buss, T.P. Chan, K.B. Sluis, N.M. Domigan, and C.C. Winterbourn Protein carbonyl measurement by a sensitive ELISA method Free Radic. Biol. Med. 23 1997 361 366 (Pubitemid 27276771)
8. G. Cao, H.M. Alessio, and R.G. Cutler Oxygen-radical absorbance capacity assay for antioxidants Free Radic. Biol. Med. 14 1993 303 311 (Pubitemid 23066371)
9. H. Chon, C.A. Gaillard, B.B. van der Meijden, H.M. Dijstelbloem, R.J. Kraaijenhagen, D. van Leenen, F.C. Holstege, J.A. Joles, H.A. Bluyssen, H.A. Koomans, and B. Braam Broadly altered gene expression in blood leukocytes in essential hypertension is absent during treatment Hypertension 43 2004 947 951 (Pubitemid 38579896)
10. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
11. M.D. Cressman, R.J. Heyka, E.P. Paganini, J. O'Neil, C.I. Skibinski, and H.F. Hoff Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients Circulation 86 1992 475 482
12. Y. Dorffel, C. Latsch, B. Stuhlmuller, S. Schreiber, S. Scholze, G.R. Burmester, and J. Scholze Preactivated peripheral blood monocytes in patients with essential hypertension Hypertension 34 1999 113 117 (Pubitemid 29325728)
13. Y. Dorffel, S. Franz, A. Pruss, G. Neumann, W. Rohde, G.R. Burmester, and J. Scholze Preactivated monocytes from hypertensive patients as a factor for atherosclerosis? Atherosclerosis 157 2001 151 160 (Pubitemid 32539365)
14. R.G. Dyer, M.W. Stewart, J. Mitcheson, K. George, M.M. Alberti, and M.F. Laker 7-ketocholesterol, a specific indicator of lipoprotein oxidation, and malondialdehyde in non-insulin dependent diabetes and peripheral vascular disease Clin. Chim. Acta 260 1997 1 13 (Pubitemid 27136408)
15. R. El Bekay, M. Alvarez, J. Monteseirin, G. Alba, P. Chacon, A. Vega, J. Martin-Nieto, J. Jimenez, E. Pintado, F.J. Bedoya, and F. Sobrino Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-kappaB Blood 102 2003 662 671 (Pubitemid 36841990)
16. L. Guasti, F. Marino, M. Cosentino, R.C. Maio, E. Rasini, M. Ferrari, L. Castiglioni, C. Klersy, G. Gaudio, A.M. Grandi, S. Lecchini, and A. Venco Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up Eur. Heart J. 29 2008 1118 1126 (Pubitemid 351844894)
17. G.A. Kaysen, and J.P. Eiserich The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction J. Am. Soc. Nephrol. 15 2004 538 548 (Pubitemid 38294783)
18. U. Kintscher, S. Wakino, S. Kim, E. Fleck, W.A. Hsueh, and R.E. Law Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytes Hypertension 37 2001 587 593 (Pubitemid 32199032)
19. P. Koobi, P. Jolma, J. Kalliovalkama, I. Tikkanen, M. Fan, M. Kahonen, E. Moilanen, and I. Porsti Effect of angiotensin II type 1 receptor blockade on conduit artery tone in subtotally nephrectomized rats Nephron. Physiol. 96 2004 91 98
20. F. Kronenberg, E. Kuen, E. Ritz, R. Junker, P. Konig, G. Kraatz, K. Lhotta, J.F. Mann, G.A. Muller, U. Neyer, W. Riegel, P. Reigler, V. Schwenger, and A. Von Eckardstein Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure J. Am. Soc. Nephrol. 11 2000 105 115 (Pubitemid 30020432)
21. J.F. Mann, H.C. Gerstein, J. Pogue, J. Bosch, and S. Yusuf Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial Ann. Intern. Med. 134 2001 629 636 (Pubitemid 32322240)
22. S. Mezzano, A. Droguett, M.E. Burgos, L.G. Ardiles, C.A. Flores, C.A. Aros, I. Caorsi, C.P. Vio, M. Ruiz-Ortega, and J. Egido Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy Kidney Int. Suppl. 2003 S64 S70
23. G. Nickenig, and D.G. Harrison The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: Part II: AT(1) receptor regulation Circulation 105 2002 530 536 (Pubitemid 34262669)
24. G. Nickenig, A. Sachinidis, F. Michaelsen, M. Bohm, S. Seewald, and H. Vetter Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells Circulation 95 1997 473 478 (Pubitemid 27056216)
25. G. Nickenig, A.T. Baumer, Y. Temur, D. Kebben, F. Jockenhovel, and M. Bohm Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men Circulation 100 1999 2131 2134
26. M. Pahor, and P. Tatti The Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET) and combination therapies Am. J. Cardiol. 83 1999 819 820 (Pubitemid 29115472)
27. I. Porsti, M. Fan, P. Koobi, P. Jolma, J. Kalliovalkama, T.I. Vehmas, H. Helin, H. Holthofer, E. Mervaala, T. Nyman, and I. Tikkanen High calcium diet down-regulates kidney angiotensin-converting enzyme in experimental renal failure Kidney Int. 66 2004 2155 2166 (Pubitemid 41115279)
28. A.M. Scanu, and J. Hinman Issues concerning the monitoring of statin therapy in hypercholesterolemic subjects with high plasma lipoprotein(a) levels Lipids 37 2002 439 444 (Pubitemid 34535306)
29. L.A. Sechi, C.A. Griffin, G. Giacchetti, J.P. Valentin, C. Llorens-Cortes, P. Corvol, and M. Schambelan Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat Hypertension 28 1996 403 408 (Pubitemid 26296042)
30. S. Sela, R. Mazor, M. Amsalam, C. Yagil, Y. Yagil, and B. Kristal Primed polymorphonuclear leukocytes, oxidative stress, and inflammation antecede hypertension in the Sabra rat Hypertension 44 2004 764 769 (Pubitemid 39435251)
31. K. Song, N. Shiota, S. Takai, H. Takashima, H. Iwasaki, S. Kim, and M. Miyazaki Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeys Atherosclerosis 138 1998 171 182 (Pubitemid 28255166)
32. N. Uhlenius, A. Miettinen, O. Vuolteenaho, and I. Tikkanen Renoprotective mechanisms of angiotensin II antagonism in experimental chronic renal failure Kidney Blood Press. Res. 25 2002 71 79 (Pubitemid 34665206)
33. J. Wagner, F. Gehlen, A. Ciechanowicz, and E. Ritz Angiotensin II receptor type 1 gene expression in human glomerulonephritis and diabetes mellitus J. Am. Soc. Nephrol. 10 1999 545 551 (Pubitemid 29117636)
34. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, and G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N. Engl. J. Med. 342 2000 145 153